Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): An open-label randomised study

Xavier Pivot, Joseph Gligorov, Volkmar Müller, Peter Barrett-Lee, Sunil Verma, Ann Knoop, Giuseppe Curigliano, Vladimir Semiglazov, Guillermo López-Vivanco, Valerie Jenkins, Nana Scotto, Stuart Osborne, Lesley Fallowfield

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preference for subcutaneous or intravenous administration of trastuzumab in patients with HER2-positive early breast cancer (PrefHer): An open-label randomised study'. Together they form a unique fingerprint.

Medicine & Life Sciences